Correlating ISEND and Tumor Mutation Burden (TMB) with Clinical Outcomes of Advanced Non-Small Cell Lung Cancer (ANSCLC) Patients on Nivolumab

被引：0
|
作者：
Park, W. [1 ]
Lopes, G. [1 ]
Kwon, D. [2 ]
Florou, V. [1 ]
Chae, Y. K. [3 ]
Warsch, J. [4 ]
Ishkanian, A. [5 ]
Jahanzeb, M. [6 ]
Mudad, R. [1 ]
机构：
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Hematol & Oncol, Miami, FL USA
[2] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Med Biostat & Bioinformat, Miami, FL USA
[3] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Dev Therapeut Program, Chicago, IL 60611 USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Radiol, Miami, FL USA
[5] Univ Miami, Sylvester Comprehens Canc Ctr, Radiat Oncol, Miami, FL USA
[6] Univ Miami, Sylvester Comprehens Canc Ctr, Med Oncol, Miami, FL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Tumor mutation burden; biomarker; Nivolumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-025
引用
收藏
页码：S2004 / S2005
页数：2
相关论文
共 50 条
  • [21] Tumor mutation score is more powerful than tumor mutation burden in predicting response to immunotherapy in non-small cell lung cancer
    Yuan Li
    Zuhua Chen
    Weiping Tao
    Nan Sun
    Jie He
    Cancer Immunology, Immunotherapy, 2021, 70 : 2367 - 2378
  • [22] Genetic and Epigenetic Alterations are Associated with Tumor Mutation Burden in Non-Small Cell Lung Cancer
    Cai, L.
    Bai, H.
    Wang, Z.
    Wang, S.
    Duan, J.
    Gao, S.
    He, J.
    Wang, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S377 - S377
  • [23] Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer
    Crino, Lucio
    Bronte, Giuseppe
    Bidoli, Paolo
    Cravero, Paola
    Minenza, Elisa
    Cortesi, Enrico
    Garassino, Marina C.
    Proto, Claudia
    Cappuzzo, Federico
    Grossi, Francesco
    Tonini, Giuseppe
    Sarobba, Maria Giuseppina
    Pinotti, Graziella
    Numico, Gianmauro
    Samaritani, Riccardo
    Ciuffreda, Libero
    Frassoldati, Antonio
    Bregni, Marco
    Santo, Antonio
    Piantedosi, Francovito
    Illiano, Alfonso
    De Marinis, Filippo
    Tamberi, Stefano
    Giannarelli, Diana
    Delmonte, Angelo
    LUNG CANCER, 2019, 129 : 35 - 40
  • [24] Clinical utility of tumor mutational burden in patients with non-small cell lung cancer treated with immunotherapy
    Hendriks, Lizza E.
    Rouleau, Etienne
    Besse, Benjamin
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 647 - 660
  • [25] Nivolumab in Elderly or Poor Performance Status Patients with Advanced Non-Small Cell Lung Cancer
    Watanabe, Sho
    Goto, Yasushi
    Motoi, Noriko
    Goto, Keiko
    Shiraishi, Hideaki
    Itahashi, Kota
    Horinouchi, Hidehito
    Kanda, Shintaro
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Ohe, Yuichiro
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1338 - S1339
  • [26] Nivolumab in routine practice for older patients with advanced or metastatic non-small cell lung cancer
    Sabatier, Renaud
    Nicolas, Emanuel
    Paciencia, Maria
    Jonville-Bera, Annie-Pierre
    Madroszyk, Anne
    Cecile, Maud
    Braticevic, Cecile
    Duran, Segolene
    Tassy, Louis
    Rouby, Franck
    Micallef, Joelle
    Rousseau, Frederique
    JOURNAL OF GERIATRIC ONCOLOGY, 2018, 9 (05) : 494 - 500
  • [27] Clinical outcomes of African American patients with advanced or metastatic non-small cell lung cancer on Nivolumab in a single community-based cancer center
    Andrew C. Tiu
    Rashmika Potdar
    Djeneba Audrey Djibo
    Muhammad Masab
    Claudia Dourado
    Medical Oncology, 2018, 35
  • [28] The safety and efficacy of nivolumab in advanced (metastatic) non-small cell lung cancer
    Tanvetyanon, Tawee
    Creelan, Benjamin C.
    Antonia, Scott J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (09) : 903 - 910
  • [29] Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Ma, Yuhui
    Li, Quan
    Du, Yaxi
    Cai, Jingjing
    Chen, Wanlin
    Zhao, Guangqiang
    Liu, Xing
    Li, Hongsheng
    Ma, Luyao
    Huang, Yunchao
    Zhou, Yongchun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Clinical outcomes of African American patients with advanced or metastatic non-small cell lung cancer on Nivolumab in a single community-based cancer center
    Tiu, Andrew C.
    Potdar, Rashmika
    Djibo, Djeneba Audrey
    Masab, Muhammad
    Dourado, Claudia
    MEDICAL ONCOLOGY, 2018, 35 (07)
12345